Advanced neural interface technology from startup Synchron allows paralyzed patients to communicate with the power of thought by implanting a secure device through their blood vessels.
Neurointerface with thoughts
Revolutionary method
The revolutionary company Synchron has developed an innovative brain-computer interface , which is implanted into the patient's brain using an endovascular approach through blood vessels. This safe and minimally invasive method allows paralyzed people to regain the ability to communicate by converting brain impulses into text or cursor movements.
Competitive Advantages
Unlike its competitors who use open-brain surgery, Synchron implants the Stentrode stent through a large vein near the motor cortex. Tiny sensors on the stent pick up brain signals and transmit them to external devices through an implanted antenna.
Following successful preliminary trials in patients in the United States and Australia with no significant side effects, Synchron is preparing for a large-scale clinical trial and is opening enrollment to potential participants.
Target Patient Populations
Synchron's technology is aimed at helping people paralyzed due to amyotrophic lateral sclerosis, stroke and multiple sclerosis. The trial in stroke patients could be particularly challenging due to potential brain damage, but the company is planning preliminary non-invasive tests to gauge prospects.
Advances and future prospects
Previous trials have shown that patients with the Synchron implant can enter text at a speed of 16 characters per minute, which exceeds the capabilities of non-invasive devices. The startup has attracted investment from big names like Jeff Bezos and Bill Gates, and recently acquired a stake in a medical components company to secure manufacturing capacity.
Although no company has yet received final approval to sell neuroimplants in the United States, Synchron is at the forefront of this revolutionary technology, promising to return the ability to communicate to paralyzed patients.
Glossary
- Synchron is a cutting-edge startup that has developed a revolutionary brain-computer neural interface.
- Stentrode is a Synchron stent equipped with tiny sensors to pick up brain signals.
- The endovascular approach is a method of implanting devices through blood vessels that is less invasive than open brain surgery.
- Jeff Bezos and Bill Gates are famous billionaire investors in Synchron.
- Neuralink is a competing company of Elon Musk that develops a neural interface.
Links
Answers to questions
What is Synchron neural interface technology?
What is the advantage of Synchron technology over its competitors?
Which patient groups can benefit from Synchron technology?
What are Synchron's achievements and prospects?
What terms are important to know in the context of Synchron technology?
Hashtags
Save a link to this article
Discussion of the topic – Neuralink, but less invasive: Synchron seeks patients for large-scale brain implant trials
Synchron has developed a secure interface for communication “with the power of thought”, implanted into the brain through blood vessels. According to Reuters, the company is preparing for a large clinical trial and is recruiting patients.
There are no reviews for this product.
Write a comment
Your email address will not be published. Required fields are checked *